Loading…
CJ CheilJedang's third-quarter bio division revenue fell 8.4% and operating profit fell 71.9%, driven by competition in tryptophan, arginine and nucleic acids and weak lysine conditions in Europe. The company is divesting non-core businesses to improve finances.
Weak lysine margins and intense competition signal oversupply in amino acids, which keeps feed additive prices under pressure.
fntimes.comYang HyunwooDec 22, 2025Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
